Aquilo Capital Management as of Sept. 30, 2022
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 15 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals (ARWR) | 14.5 | $40M | 1.2M | 33.05 | |
| S&p Biotech Etf Tr Unit Put Option (XBI) | 14.3 | $40M | 500k | 79.32 | |
| Blueprint Medicines (BPMC) | 12.5 | $35M | 524k | 65.89 | |
| Merus N V (MRUS) | 10.9 | $30M | 1.5M | 20.03 | |
| Arvinas Ord (ARVN) | 10.8 | $30M | 672k | 44.49 | |
| Regenxbio Inc equity us cm (RGNX) | 9.2 | $26M | 968k | 26.43 | |
| Uniqure Nv SHS (QURE) | 5.7 | $16M | 842k | 18.76 | |
| Amryt Pharma Sponsored Ads | 5.0 | $14M | 2.0M | 6.92 | |
| Silence Therapeutics Ads (SLN) | 4.6 | $13M | 1.3M | 10.03 | |
| Argenx Se Sponsored Adr (ARGX) | 3.1 | $8.5M | 24k | 353.04 | |
| Genmab A/s Sponsored Ads (GMAB) | 2.8 | $7.9M | 245k | 32.13 | |
| Kymera Therapeutics (KYMR) | 2.6 | $7.2M | 330k | 21.77 | |
| Spero Therapeutics (SPRO) | 2.5 | $6.8M | 3.4M | 2.00 | |
| Pieris Pharmaceuticals | 1.7 | $4.6M | 4.0M | 1.15 | |
| 4d Molecular Therapeutics In (FDMT) | 0.0 | $29k | 3.6k | 8.12 |
